GIA
UTHR icon

Gateway Investment Advisers’s United Therapeutics UTHR Stock Holding History

Gateway Investment Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
2,572
+1,388
+117% +$782K 0.01% 363
2026
Q1 		$702K Buy
1,184
+243
+26% +$121K 0.01% 404
2025
Q4 		$459K Hold
941
– – ﹤0.01% 454
2025
Q3 		$394K Sell
941
-4
-0.4% -$1.34K ﹤0.01% 431
2025
Q2 		$272K Buy
945
+1
+0.1% +$299 ﹤0.01% 435
2025
Q1 		$291K Sell
944
-17
-2% -$5.83K ﹤0.01% 448
2024
Q4 		$339K Sell
961
-391
-29% -$144K ﹤0.01% 426
2024
Q3 		$484K Hold
1,352
– – 0.01% 390
2024
Q2 		$431K Buy
1,352
+394
+41% +$104K ﹤0.01% 399
2024
Q1 		$220K Buy
+958
New +$216K ﹤0.01% 484

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Gateway Investment Advisers's UTHR Position: Q2 2026 in Review

Gateway Investment Advisers increased its United Therapeutics (UTHR) stake by 117% in Q2 2026, buying an estimated $782K and bringing the position to 2,572 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #363.

Gateway Investment Advisers first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Gateway Investment Advisers held 2,572 shares of United Therapeutics worth $1.39M as of Q2 2026.
  • Gateway Investment Advisers bought 1,388 United Therapeutics shares in Q2 2026, an estimated $782K.
  • United Therapeutics made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #363 holding.
  • Gateway Investment Advisers first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.